With the latest report on fertility treatment add-ons from the ESHRE revealing that clinics are implementing treatments with an unproven success rate into their care plans, Bridge Clinic London is calling for greater financial transparency in order to protect patients’ best interests.
ABBV-400 by AbbVie for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug